Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/55711
Full metadata record
DC FieldValueLanguage
dc.creatorR.huerta-gutiérrezpt_BR
dc.creatorRayo Morfín-oteropt_BR
dc.creatorp. Rodríguez-zuluetapt_BR
dc.creatora. Rosado-buzzopt_BR
dc.creatorFernando Rosso-suárezpt_BR
dc.creatorWanessa Trindade Clementept_BR
dc.creatorDenusa Wiltgenpt_BR
dc.creatorl. Bragapt_BR
dc.creatora. Camacho-ortizpt_BR
dc.creatorHumberto Díaz-poncept_BR
dc.creatorl. García-mollinedopt_BR
dc.creatorm. Guzmán-blancopt_BR
dc.creators. Valderrama-beltránpt_BR
dc.creatore. Landaeta-nezerpt_BR
dc.creators. Moreno-espinosapt_BR
dc.date.accessioned2023-07-03T22:17:43Z-
dc.date.available2023-07-03T22:17:43Z-
dc.date.issued2019-06-15-
dc.citation.volume86pt_BR
dc.citation.spage157pt_BR
dc.citation.epage166pt_BR
dc.identifier.doi10.1016/j.ijid.2019.06.016pt_BR
dc.identifier.issn12019712pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/55711-
dc.description.resumoBackground and aims: Experience in the region shows that in some countries there is very good surveillance of Healthcare-associated infections (HAIs) in health services, but there is no national data consistently in all countries. Therefore, we set to estimate the total burden of HAIs and antimicrobial use in acute care hospitals in Brazil, Venezuela, Mexico, and Colombia using the one-day point prevalence methodology. Methods: The survey was conducted between June and July 2016. In each ward or unit, HAIs and antimicrobial use data were collected on a single day by a trained team of researchers. Also, for each patient, we collected data on risk factors for infections. Results: One out of ten individuals surveyed had at least one healthcare-associated infection (HAI).Pneumonia and surgical site infections were the most relevant among the surveyed countries. Most of the surveyed participants, regardless of their HAI status, received antibiotics except the individuals managed in Brazil. Carbapenems and third-generation Cephalosporins were among the most frequently used antibiotics. Conclusion: Our results add to WHO’s recent efforts to understand HAIs prevalence and antibiotic consumption in low and middle-income countries, of which we studied three that were not included in their last report.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE PROPEDÊUTICA COMPLEMENTARpt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofInternational Journal of Infectious Diseases-
dc.rightsAcesso Abertopt_BR
dc.subjectHealthcare-associated infectionspt_BR
dc.subjectAntibioticspt_BR
dc.subjectOne day prevalencept_BR
dc.subjectPublic hospitalspt_BR
dc.subjectInfectious Disease Medicinept_BR
dc.subjectNosocomial infectionspt_BR
dc.subject.otherInfecção Hospitalarpt_BR
dc.subject.otherAntibacterianospt_BR
dc.subject.otherHospitais Públicospt_BR
dc.subject.otherinfectologiapt_BR
dc.titleOne-day point prevalence of healthcare-associated infections and antimicrobial use in four countries in Latin Americapt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.sciencedirect.com/science/article/pii/S1201971219302619?via%3Dihubpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-0848-3740pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
One day point prevalence of healthcare associated infections and pdfa.pdf293.15 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.